These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29628214)

  • 21. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH; Feinberg SS; Feldman RG
    JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preface: Malignant syndrome in Parkinson's disease.
    Narabayashi H; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S1. PubMed ID: 12735908
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
    Hirschorn KA; Greenberg HS
    Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome complicating levodopa withdrawal.
    Reutens DC; Harrison WB; Goldswain PR
    Med J Aust; 1991 Jul; 155(1):53-4. PubMed ID: 2067442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome.
    Mueller PS
    Psychosomatics; 1985 Aug; 26(8):654-62. PubMed ID: 2863852
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O; Salachas F; Montastruc JL
    Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group.
    Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptic malignant-like syndrome following abrupt withdrawal of baclofen].
    Adeva-Bartolomé MT; Alonso-Navarro H; Martín-Prieto M; Jiménez-Jiménez FJ
    Med Clin (Barc); 2006 Jun; 127(2):79. PubMed ID: 16801014
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
    Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
    No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
    Fiore S; Persichino L; Anticoli S; De Pandis MF
    Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.
    Wu YF; Kan YS; Yang CH
    Gen Hosp Psychiatry; 2011; 33(3):301.e7-8. PubMed ID: 21601731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome and amantadine withdrawal.
    Lazarus A
    Am J Psychiatry; 1985 Jan; 142(1):142. PubMed ID: 3966578
    [No Abstract]   [Full Text] [Related]  

  • 36. [Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Sunohara N
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study.
    Takubo H; Shimoda-Matsubayashi S; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S43-6. PubMed ID: 12735914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK; Seegers S
    Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
    [No Abstract]   [Full Text] [Related]  

  • 39. Apomorphine in malignant syndrome due to levodopa withdrawal.
    Bonuccelli U; Piccini P; Corsini GU; Muratorio A
    Ital J Neurol Sci; 1992 Mar; 13(2):169-70. PubMed ID: 1592579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome associated with withdrawal from carbamazepine.
    Keepers GA
    Am J Psychiatry; 1990 Dec; 147(12):1687. PubMed ID: 2244648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.